medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2006, Number 6

<< Back Next >>

Rev Invest Clin 2006; 58 (6)

Seropositivity of HIV, HBV, HCV and Treponema pallidum in blood donors in Southeast Mexico

García-Montalvo BM

Language: Spanish
References: 38
Page: 567-572
PDF size: 61.29 Kb.


ABSTRACT

Objective. To determine the prevalence of serological markers for the human immunodeficiency virus (HIV), hepatitis B (HVB) and C (HCV) viruses, and Treponema pallidum in blood donors. Material and methods. The results of the screening tests from blood donors studied at the Central Blood Bank of the Ignacio Garcia Tellez National Medical Center, in Merida, Yucatan, Mexico between January 2002 and December 2004, have been retrospectively evaluated. Results. Of 39,933 blood donors, 424 (1.06%) were positive to one or more serological markers. The seropositivity rates for anti-HIV, HBsAg, anti-HCV and anti-Treponema pallidum were found as 0.13%, 0.20%, 0.44% and 0.29%, respectively. Western Blot positive was found in 41 (77.36%) of the 53 blood donors positive for anti-HIV. Conclusions. In this study, the prevalence of serological markers was similar or lower than that reported in previous studies in Mexico.


REFERENCES

  1. Kitchen A. Hepatitis B and blood safety. Vaccine 1998; 16: 345-75.

  2. Saraswat S, Banerjee K, Chaudhury N, Mahant T, Khandekar P, Gupta RK, et al. Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol 1996; 25: 639-43.

  3. Ling AE, Robbins KE, Brown TM, Dunmire V, Thoe SY, Wong SY, et al. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. JAMA 2000; 284: 210-14.

  4. Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K, et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 2000; 31: 488-95.

  5. Moor AC, Dubbelman TM, Van Steveninck J, Brand A. Transfusion- transmitted diseases: risks, prevention and perspectives. Eur J Haematol 1999; 62: 1-8.

  6. Cruz JR, Pérez-Rosales MD. Availability, safety, and quality of blood for transfusion in the Americas. Rev Panam Salud Pública 2003; 13: 103-10.

  7. Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005; 45: 133-40.

  8. Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, et al. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43: 696-704.

  9. Dreier J, Kröger M, Diekmann J, Götting C, Kleesiek K. Lowlevel viraemia of hepatitis B virus in an anti-HBc- and anti-HBspositive blood donor. Transfusion Med 2004; 14: 97-103.

  10. Infectious disease testing for blood transfusions. NIH Consensus Statement 1995; 13: 1-27.

  11. Secretaría de Salud (México). Normas y Técnicas para la disposición de sangre humana con fines terapéuticos. Diario Oficial de la Federación del 22 de mayo de 1986.

  12. Norma Oficial Mexicana NOM-003-SSA2-1993, para la disposición de sangre humana y sus componentes con fines terapéuticos. Diario Oficial de la Federación del 18 de julio de 1994. p. 61-92.

  13. Secretaría de Salud. Dirección General de Epidemiología. Registro Nacional de Casos de SIDA. Datos al 15 de noviembre de 2005. CONASIDA, México.

  14. Sentjens RE, Sisay Y, Vrielink H, Kebede D, Ader HJ, Leckie G, et al. Prevalence of and risk factors for HIV infection in blood donors and various population subgroups in Ethiopia. Epidemiol Infect 2002; 128: 221-8.

  15. Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol 2001; 44: 409-12.

  16. Rivera-López MRF, Zavala-Méndez C, Arenas-Esqueda A. Prevalencia de seropositividad para VIH, hepatitis B y C en donadores de sangre. Gac Med Mex 2004; 140: 657-60.

  17. Carreto-Vélez MA, Carrada-Bravo T, Martínez-Magdaleno A. Seroprevalencia de VHB, VHC y VIH en donadores de sangre en Irapuato, México. Salud Pública Méx 2003; 45(Supl.) 5: S690-S693.

  18. Vázquez-Flores JA, Valiente-Banuet L, Marín y López RA, Sánchez-Guerrero SA. La seguridad de las reservas sanguíneas en la República Mexicana durante los años 1999 a 2003. Rev Invest Clin 2006; 58: 101-8.

  19. Ayala-Gaytán JJ, Guerra-Ávalos FJ, Mora-Brondo P, Casillas-Romo A. Prevalencia de marcadores virales para hepatitis B, C y virus de la inmunodeficiencia humana en donadores de sangre voluntarios en el Noreste de México. Rev Gastroenterol Méx 1997; 62: 250-3.

  20. Pita-Ramírez L, Torres-Ortiz GE. Prevalencia de anticuerpos virales y reaginas luéticas en donadores de sangre de un hospital. Rev Invest Clin 1997; 49: 475-80.

  21. Zuckerman AJ, Zuckerman JN. Current topics in hepatitis B. J Infection 2000; 41: 130-6.

  22. Rosini N, Mousse D, Spada C, Treitinger A. Seroprevalence of HBsAg, anti-HBc y anti-HCV in southern Brazil, 1999-2001. Braz J Infect Dis 2003; 7: 262-7.

  23. Gutiérrez C, Devesa M, Loureiro CL, León G, Liprandi F, Pujol FH. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. J Med Virol 2004; 73: 200-7.

  24. Farfan G, Cabezas C. Prevalence of viral hepatitis type C in blood donors in Peru. Rev Gastroenterol Perú 2003; 23: 171-6.

  25. Méndez-Sánchez N, Baptista-González H, Sánchez-Gómez RH, Bordes-Aznar J, Uribe-Esquivel M. Prevalencia de hepatitis B y C en donadores de sangre en un hospital de tercer nivel de la ciudad de México. Salud Pública Méx 1999; 41: 475-8.

  26. Rivas-Llamas R. Seroprevalencia y tendencia de la infección por VIH, VHB y VHC en donadores de sangre en la ciudad de Culiacán. Rev Med IMSS 1996; 34: 487-93.

  27. WHO. Global surveillance and control of hepatitis C. Report of a WHO consultation organized with the Viral Hepatitis Prevention Board. Antwerp, Belgium. J Viral Hepat 1999; 6: 35-47.

  28. Di Bisceglie AM. Hepatitis C. Lancet 1998; 351: 351-5.

  29. Muller Z, Deak J, Horanyi M, Szekeres E, Nagy I, Ozsvar Z, et al. The detection of hepatitis C virus in south Hungary. J Clin Virol 2001; 20: 81-3.

  30. Zou S, Notari EP 4th, Stramer SL, Wahab F, Musavi F, Dodd RY; ARCNET Research Group. Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donors study. Transfusion 2004; 44: 1640-7.

  31. Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form. Southeast Asian J Trop Med Public Health 2004; 35: 147-54.

  32. Butsashvili M, Tsertsvadze T, McNutt LA, Kamkamidze G, Gvetadze R, Badridze N. Prevalence of hepatitis B, Hepatitis C, syphilis and HIV in Gregorian blood donors. Eur J Epidemiol 2001; 17: 693-5.

  33. Halim NK, Ajayi OI. Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria. East Afr Med J 2000; 77: 410-12.

  34. Guerrero-Romero JF, Castañeda A, Rodríguez-Morán M. Prevalencia y factores de riesgo asociados a hepatitis “C” en donadores de sangre en el municipio de Durango, México. Salud Pública Méx 1996; 38: 94-100.

  35. Gunduz T, Mumcuoglu I, Garay M. Evaluation of hepatitis B surface antigen, anti-hepatitis C virus and anti-human immunodeficiency virus antibodies and syphilis seropositivity in blood donors: six years seropositivity. Int J Clin Pharmacol Res 2005; 25: 155-8.

  36. Monteón-Padilla VM, Hernández-Becerril N, Guzmán-Bracho C, Rosales-Encina JL, Reyes-López PA. American trypanosomiasis (Chagas’ disease) and blood banking in Mexico city: seroprevalence and its potential transfusional transmission risk. Arch Med Res 1999; 30: 393-8.

  37. Servicios de Salud de Yucatán. Vigilancia Epidemiológica de VIH/SIDA. Base de Datos hasta el 30 de septiembre de 2005.

  38. Elemuwa CO, Bassey BE, Olaleye DO. The problems of indeterminate HIV results in blood transfusion services in Nigeria. Trop Doct 2005; 35: 166-7.




2020     |     www.medigraphic.com